Nosocomial infections and multidrug-resistant organisms in Germany: Epidemiological data from KISS (The Hospital Infection Surveillance System);Nosokomiale infektionen und multiresistente erreger in Deutschland: Epidemiologische daten aus dem Krankenhaus-Infektions-Surveillance-System

Deutsches Arzteblatt

Volumn 108, Issue 6, 2011, Pages 87-93

  Geffers, Christine ^a   Gastmeier, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BLOODSTREAM INFECTION; CENTRAL VENOUS CATHETER; CLOSTRIDIUM DIFFICILE INFECTION; DEVICE INFECTION; GERMANY; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; RISK ASSESSMENT; SEPSIS; SURGICAL PATIENT; URINARY CATHETER; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 79952510722     PISSN: 00121207     EISSN: 01722107     Source Type: Journal    
DOI: 10.3238/arztebl.2011.0087     Document Type: Article

References (25)

1. Geffers C, Sohr D, Gastmeier P: Mortality attributable to hospital-acquired infections among surgical patients. Infect Control Hosp Epidemiol 2008; 29: 1167-70.
2. Aranaz-Andres JM, Aibar-Remon C, Vitaller-Murillo J, et al.: Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events. J Epidemiol Community Health 2008; 62: 1022-9.
3. Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. Jama 1994; 271: 1598-601.
4. Beyersmann J, Gastmeier P, Grundmann H, et al.: Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006; 27: 493-9. (Pubitemid 43835532)
5. Rioux C, Grandbastien B, Astagneau P: Impact of a six-year control programme on surgical site infections in France: results of the INCISO surveillance. J Hosp Infect 2007; 66: 217-23. (Pubitemid 46979846)
6. Gastmeier P, Schwab F, Sohr D, Behnke M, Geffers C: Reproducibility of the surveillance effect to decrease nosocomial infection rates. Infect Control Hosp Epidemiol 2009; 30: 993-9.
7. Geubbels EL, Nagelkerke NJ, Mintjes-De Groot AJ, et al.: Reduced risk of surgical site infections through surveillance in a network. Int J Qual Health Care 2006; 18: 127-33.
8. Anonymus: Surveillance nosokomialer Infektionen sowie die Erfassung von Erregern mit speziellen Resistenzen und Multiresistenzen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2000: 887-90.
9. Geffers C, Koch J, Sohr D, et al.: Establishment of a national database for ICU-associated infections. First results from the "Krankenhaus- Infections-Surveillance-System" (KISS). Anaesthesist 2000; 49: 732-7.
10. NRZ. Definitionen nosokomialer Infektionen (CDC-Definitionen). http://www.nrz-hygiene.de/dwnld/CDC-Definitionen-Stand04-2008-6Auflage2008.pdf
11. Zuschneid I, Rucker G, Schoop R, et al.: Representativeness of the surveillance data in the intensive care unit component of the German nosocomial infections surveillance system. Infect Control Hosp Epidemiol 2010; 31: 934-8.
12. Zuschneid I, Geffers C, Sohr D, et al.: Validation of surveillance in the intensive care unit component of the German nosocomial infections surveillance system. Infect Control Hosp Epidemiol 2007; 28: 496-9. (Pubitemid 46658068)
13. NRZ. Referenzdaten ITS-KISS. http://www.nrz-hygiene.de/dwnld/RefDaten/ 200501-200912-ITS-reference.pdf
14. Statistisches, Bundesamt. Grunddaten der Krankenhäuser. https://www-ec.destatis.de/csp/shop/sfg/bpm.html.cms.cBroker.cls?cmspath= struktur,vollanzeige.csp&ID=1024819
15. Chaberny IF, Sohr D, Ruden H, Gastmeier P: Development of a surveillance system for methicillin-resistant Staphylococcus aureus in German hospitals. Infect Control Hosp Epidemiol 2007; 28: 446-52. (Pubitemid 46658058)
16. Rüden H, Daschner F, Schumacher M: Nosokomiale Infektionen in Deutschland: Erfassung und Prävention (NIDEP-Studie); Teil 1: Prävalenz nosokomialer Infektionen; Qualitätssicherung in der Krankenhaushygiene. Baden-Baden: Nomos Verlagsgesellschaft 1995.
17. Harbarth S, Sax H, Gastmeier P: The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003; 54: 258-66; quiz 321.
18. Edwards JR, Peterson KD, Mu Y, et al.: National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37: 783-805.
19. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J: Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160: 608-13. (Pubitemid 29380680)
20. Rello J, Torres A: Microbial causes of ventilator-associated pneumonia. Semin Respir Infect 1996; 11: 24-31. (Pubitemid 26104521)
21. Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in coronary care units in the United States. National Nosocomial Infections Surveillance System. Am J Cardiol 1998; 82: 789-93.
22. Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 887-92. (Pubitemid 29266004)
23. Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1999; 103: e39.
24. Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA: Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001. Int J Antimicrob Agents 2004; 23: 577-81. (Pubitemid 38759673)
25. Paul-Ehrlich-Gesellschaft. Studie 2007. http://www.p-e-g.org/ag- resistenz/main.htm